• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2012 - Product Image

Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2012

  • Published: November 2012
  • Region: Global
  • 169 pages
  • GlobalData

Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2012

Summary

Our clinical trial report, “Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2012" provides data on the Idiopathic Pulmonary Fibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Idiopathic Pulmonary Fibrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Idiopathic Pulmonary Fibrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, READ MORE >

List of Tables
List of Figures
Introduction
Idiopathic Pulmonary Fibrosis
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Idiopathic Pulmonary Fibrosis
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
InterMune, Inc.
Clinical Trial Overview of InterMune, Inc.
Actelion Ltd
Clinical Trial Overview of Actelion Ltd
Boehringer Ingelheim GmbH
Clinical Trial Overview of Boehringer Ingelheim GmbH
Novartis AG
Clinical Trial Overview of Novartis AG
Gilead Sciences, Inc.
Clinical Trial Overview of Gilead Sciences, Inc.
Sanofi
Clinical Trial Overview of Sanofi
FibroGen, Inc.
Clinical Trial Overview of FibroGen, Inc.
Promedior, Inc.
Clinical Trial Overview of Promedior, Inc.
LTT Bio-Pharma Co., Ltd.
Clinical Trial Overview of LTT Bio-Pharma Co., Ltd.
Lung Rx, Inc.
Clinical Trial Overview of Lung Rx, Inc.
Stromedix, Inc.
Clinical Trial Overview of Stromedix, Inc.
Fresenius Biotech GmbH
Clinical Trial Overview of Fresenius Biotech GmbH
Pharmaxis Limited
Clinical Trial Overview of Pharmaxis Limited
Novartis Pharmaceuticals Corporation
Clinical Trial Overview of Novartis Pharmaceuticals Corporation
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Arresto Biosciences, Inc.
Clinical Trial Overview of Arresto Biosciences, Inc.
Zambon Company S.p.A.
Clinical Trial Overview of Zambon Company S.p.A.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Cipla Ltd.
Clinical Trial Overview of Cipla Ltd.
MedImmune, LLC
Clinical Trial Overview of MedImmune, LLC
Clinical Trial Overview of Top Universities / Institutes / Hospitals
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
Kinki University School of Medicine
Clinical Trial Overview of Kinki University School of Medicine
University of California, Los Angeles
Clinical Trial Overview of University of California, Los Angeles
New York University School of Medicine
Clinical Trial Overview of New York University School of Medicine
University of Michigan
Clinical Trial Overview of University of Michigan
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Rabin Medical Center
Clinical Trial Overview of Rabin Medical Center
The University of Nottingham
Clinical Trial Overview of The University of Nottingham
Toho University
Clinical Trial Overview of Toho University
Academic Medical Centre
Clinical Trial Overview of Academic Medical Centre
Saitama Medical University
Clinical Trial Overview of Saitama Medical University
The University of Chicago
Clinical Trial Overview of The University of Chicago
University of Virginia
Clinical Trial Overview of University of Virginia
Hiroshima University Hospital
Clinical Trial Overview of Hiroshima University Hospital
Columbia University
Clinical Trial Overview of Columbia University
Dresden University of Technology
Clinical Trial Overview of Dresden University of Technology
Sheba Medical Center
Clinical Trial Overview of Sheba Medical Center
University Hospital Freiburg
Clinical Trial Overview of University Hospital Freiburg
The Ohio State University
Clinical Trial Overview of The Ohio State University
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Idiopathic Pulmonary Fibrosis Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, North America, Top Countries, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, BRIC Countries, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, G7 Countries, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, E7 Countries, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by InterMune, Inc., 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by FibroGen, Inc., 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Promedior, Inc., 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by LTT Bio-Pharma Co., Ltd., 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Lung Rx, Inc., 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Stromedix, Inc., 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fresenius Biotech GmbH, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmaxis Limited, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Pharmaceuticals Corporation, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Arresto Biosciences, Inc., 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zambon Company S.p.A., 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cipla Ltd., 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kinki University School of Medicine, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Nottingham, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Toho University, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba Medical Center, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2012-

List of Figures
Idiopathic Pulmonary Fibrosis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, BRIC Countries (%), 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, G7 Countries (%), 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, E7 Countries (%), 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Idiopathic Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos